Lung Cell Differentiation Protocol for Robust hiPSC-Derived Progenitors
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current protocols lack a robust and efficient method for differentiating stem cells to obtain lung epithelial cells, particularly proximal and distal lung epithelial cells, which are crucial for understanding and addressing respiratory disorders like COPD and asthma.
Innovation Solution
A unified in-vitro process involving sub-culturing human pluripotent stem cells to form embryoid bodies, followed by plating and culturing in definitive endoderm, anteriorization, and specific differentiation media to obtain proximal and distal lung epithelial cells, mimicking in-vivo organogenesis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If various protocols are used for differentiating stem cells to obtain lung cells, then lung cells can be obtained, but the process lacks robustness and efficiency
Solution Approach 1:
The differentiation protocol is divided into five distinct sequential phases (definitive endoderm induction, anteriorization, proximal specification, distal specification, and alveolar differentiation) with specific timeframes and media compositions for each stage. This segmentation allows precise control over cell fate decisions and improves both reliability and efficiency of obtaining authentic lung epithelial cells from pluripotent stem cells
Solution Approach 2:
The protocol performs preliminary actions by first inducing definitive endoderm cells before proceeding to lung-specific differentiation. The anteriorization medium is applied in advance to establish the correct cellular context before introducing proximal or distal specification factors. This preliminary establishment of cell identity ensures subsequent differentiation steps are more efficient and reliable
2Ease of manufacture
If existing differentiation protocols are used, then lung cells can be obtained, but there is a knowledge gap in designing a robust and efficient protocol
Solution Approach 1:
The protocol systematically changes multiple parameters including media composition (definitive endoderm medium, anteriorization medium, proximal/distal specification media), growth factor concentrations (Activin A, BMP4, FGF10, WNT3A), and time duration for each differentiation stage. These controlled parameter changes enable reliable generation of authentic lung epithelial cells while maintaining ease of implementation through standardized procedures
3Productivity
If stem cells are differentiated using current methods, then lung cells can be obtained, but the process is not efficient for obtaining large numbers of authentic lung progenitors
Solution Approach 1:
The differentiation protocol maintains continuous useful action by seamlessly transitioning cells through each differentiation stage without prolonged pauses or intermediate rest periods. Each phase (definitive endoderm, anteriorization, proximal/distal specification) is designed to flow continuously into the next, maximizing cell production efficiency while maintaining authenticity of lung progenitors within a total timeframe of approximately 21-28 days
Data Source
AI summary
Disclosed is an in-vitro protocol for differentiating human induced pluripotent stem cells (hiPSCs) or human embryonic stem cells (hESC) to give rise to a definitive endoderm, followed by progression into anteriorized foregut endoderm that has the ability to give rise to both proximal and distal lung epithelial cells. The protocol not only offers great opportunities for the study of human development but also have tremendous potential for future clinical cell-based therapies. The protocol outlined here is used to differentiate hiPSCs into lung epithelial cell types through a process that faithfully recapitulates the stepwise events observed in-vivo. The was followed with the working cell bank of an hiPSC line made under current Good Manufacturing Practice (cGMP) conditions, a necessary step for the future clinical application of these cells.